Cancer Therapy South Burlington VT

Cancer can affect every part of the body. Cancer treatment varies widely and may include anti-cancer drugs, radiation therapy, chemotherapy, surgery, biological therapies, bone marrow transplantations, targeted cancer therapies, and others. See below to learn more and to gain access to oncologists in South Burlington, VT who provide cancer therapy.

Vermont Cancer Center at the University of Vermont
(802) 656-4414
89 Beaumont Avenue
Burlington, VT
Clinic Type
Cancer

Data Provided by:
David Nielsen Krag
(802) 656-5830
111 Colchester Ave
Burlington, VT
Specialty
Surgical Oncology

Data Provided by:
Dr.Steven Grunberg
(802) 847-8400
111 Colchester Avenue
Burlington, VT
Gender
M
Education
Medical School: Cornell Univ Med Coll
Year of Graduation: 1975
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
2.5, out of 5 based on 1, reviews.

Data Provided by:
Barbara Winslow Grant
(802) 847-8400
111 Colchester Ave
Burlington, VT
Specialty
Hematology / Oncology

Data Provided by:
Joseph D Dickerman
(802) 847-8200
111 Colchester Ave
Burlington, VT
Specialty
Pediatric Hematology-Oncology

Data Provided by:
Lawrence Edward McCahill
(802) 847-2261
111 Colchester Ave
Burlington, VT
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Cheung Wong, MD
(201) 678-1899
111 Colchester Ave
Burlington, VT
Specialties
Oncology (Cancer), Gynecological Oncology
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1992

Data Provided by:
Harold James Wallace III, MD
(802) 847-3506
111 Colchester Ave
Burlington, VT
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Vt Coll Of Med, Burlington Vt 05405
Graduation Year: 1988
Hospital
Hospital: Fletcher Allen Health Care, Burlington, Vt
Group Practice: Radiation Oncology

Data Provided by:
Jeffrey B Davis
(802) 847-4531
1 S Prospect St
Burlington, VT
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Harold James Wallace
(802) 847-3506
111 Colchester Ave
Burlington, VT
Specialty
Radiation Oncology

Data Provided by:
Data Provided by:

Female Dangers

While breast cancer is the biggest and most publicized cancer threat American
women face, it is not the only female-specific cancer. Cervical, ovarian and uterine
malignancies affect thousands each year. Learn what to look out for so you don’t fall victim.

By Lisa James

May 2006

If someone says the words “female” and “cancer” to you, the first word that probably pops into your head is “breast.” After all, the numbers are hard to ignore: Almost 213,000 American women develop breast malignancies each year…and more than 40,000 die from them.

But a woman overlooks her reproductive tract at her peril; just ask actress Fran Drescher, who graced the cover of last year’s Annual ET Cancer Issue. In her book, Cancer Schmancer (Warner Books), Drescher explains how she saw nine doctors—count ’em, nine—before her uterine cancer was finally discovered and treated, leaving her unable to bear children. “Women need to understand gynecological cancers and the tests that can help detect them,” she writes. “We have to…become educated consumers, network among ourselves, and gain information and insight into getting diagnosed and getting treatment. Someone gimme a podium!”

Taking our lead from “The Nanny,” ET presents what you need to know about three cancers—cervical, ovarian and uterine—that should be on every woman’s radar. (Statistics given are 2006 estimates from the American Cancer Society [ACS].)

Uterine Cancer: A Hormonal Challenge

What it is: Most are endometrial cancers; they arise in the inner lining (endometrium) of the uterus, the part that grows and is shed over the course of a woman’s menstrual cycle. Tumors called sarcomas can develop in the muscle tissue, but account for only 2% to 4% of all uterine cancers.
Number of women affected: 41,200 cases of endometrial cancer (the most common reproductive-tract malignancy) and 7,350 deaths. It is one of the more treatable cancers though, with a five-year survival rate of 84%.

At greatest risk: Roughly 70% of all women affected are between the ages of 45 and 74. Endometrial cancer shares a lot of risk factors with ovarian cancer because excessive estrogen exposure promotes overgrowth of the uterine lining. Taking the drug tamoxifen for breast cancer also increases risk, as does having undergone pelvic radiation therapy. Genetic history is another factor, particularly in families affected by hereditary nonpolyposis colon cancer (HNPCC).

The symptoms: Abnormal bleeding, especially after menopause. Pain and weight loss can be signs of late-stage disease.

The tests: There are no standard screening tests for this kind of cancer. Abnormal bleeding may prompt your doctor to perform an endometrial biopsy, in which a thin needle is passed through the cervical opening to collect cells in the uterine lining.

Vital info: Try your best to drop those extra pounds. Obesity ups the risk of hormonally driven cancers because fat tissue can transform other hormones into estr...

Click here to read the rest of this article from Energy Times